The Programme d'accompagnement justice-santé mentale (PAJ-SM) at the Montreal Municipal Court.

The laboratory’s focus is on the neurons that use glutamate, an excitatory neurotransmitter that is key to the functioning of the central nervous system.

Directed by Cécilia Flores, PhD, the laboratory investigates brain abnormalities at the cellular and molecular level contributing to behaviours associated with schizophrenia and addiction.

Directed by N.M.K. Ng Ying Kin, PhD, the laboratory measures putative biological markers for various psychiatric conditions and treatment-resistance to usual medications.

In 1982, after consultation with the Canadian government, the Director-General of WHO designates the Douglas Mental Health University Institute as the first Collaborating Centre for research and training in mental health in Canada.

Lectures are accredited and are open to psychiatrists, physicians, dentists, pharmacists, residents, students and health partners. They allow participants to talk directly with various professionals and experts in mental health.

All laboratory projects require and utilize a multidisciplinary approach, ranging from behavioral models to cellular events, involving the latest technology.

The research team of the neuroimmunology laboratory.

Directed by Giamal Luheshi, PhD, the lab investigates the interactions between the peripheral immune system and the brain during infection and inflammation.

The lab team studies the effect of prenatal stress on childhood development and the various risk factors associated with schizophrenia.